Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
HUMA Humacyte
3.230+0.150+4.87%
Close
02/03 16:00 ET
3.240+0.010+0.31%
Post Mkt Price 02/03 16:30 ET
High
3.320
Open
3.040
Turnover
607.89K
Low
3.010
Pre Close
3.080
Volume
189.06K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Humacyte Announces Publication of 6-year Outcomes in Phase 2 Study of HAV
Humacyte Publication in the Journal of Vascular Surgery – Vascular Science Reports the Human Acellular Vessel™ (HAV™) Remains Durable at Six Years In Patients With Peripheral Artery Disease
- HAVs observed to provide long-term perfusion to patients with critical limb ischemia - 3D Angiograms show mechanical durability of engineered human blood vessels DURHAM, N.C., Jan. 24, 2023 (GLOBE
MGNI, BIOR and VERV Are Among After Hour Movers
Humacyte (NASDAQ:HUMA) & Relay Therapeutics (NASDAQ:RLAY) Financial Analysis
Humacyte (NASDAQ:HUMA – Get Rating) and Relay Therapeutics (NASDAQ:RLAY – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the s
Critical Review: Humacyte (NASDAQ:HUMA) & Relay Therapeutics (NASDAQ:RLAY)
Humacyte (NASDAQ:HUMA – Get Rating) and Relay Therapeutics (NASDAQ:RLAY – Get Rating) are both medical companies, but which is the better stock? We will contrast the two businesses based on the stren
Sidoti's January Micro-Cap Conference
NEW YORK, NY / ACCESSWIRE / January 17, 2023 / Sidoti & Company, LLC has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference taking place Wednesday and Thursda
5 Value Stocks In The Healthcare Sector
What are Value Stocks?A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be undervalued, as investors ar
CLNE, IOVA and ATRA Are Among After Hour Mover
Stocks That Hit 52-Week Lows On Wednesday
 On Wednesday, 152 stocks made new 52-week lows. Areas of Interest About Today's 52-Week Lows: Tesla (NASDAQ:TSLA) was the largest firm on a market cap basis to set a new 52-week low.Pingtan Marine
Humacyte (NASDAQ:HUMA) Price Target Cut to $5.00
Humacyte (NASDAQ:HUMA – Get Rating) had its target price lowered by investment analysts at Cowen from $8.00 to $5.00 in a research note issued to investors on Monday, The Fly reports. Cowen's price
Company Overview
More
Humacyte, Inc. engages in the manufacture of human acellular matrix products for vascular and non-vascular applications. It offers its products to the cardiovascular, cosmetic, soft tissue reconstruction, neurosurgical, and orthopedic markets. The company was founded by Laura E. Niklason and Juliana L. Blum in October 13, 2004 and is headquartered in Durham, NC.
CEO： Ms. Laura E. Niklason
Market： NASDAQ
Listing Date： 12/01/2020
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet